Partnerships

Over the last couple of years we have established valuable partnerships and collaborations with renowned institutes and academics to level up our product.

Our Research Partners

NAR/VU Amsterdam

Blinklab Expands Autism Diagnostics into Adults Through a New Collaboration with VU Amsterdam and NAR

Princeton

Smartphone-based neurobehavioral testing in the blink of an eye

Monash (Magnet)

BlinkLab to Collaborate with Landmark Monash University Autism/ADHD (MAGNET) Project Investigators

Monash (Ketamine)

The Pharmacology of Human Decision Making Study with Monash University

Erasmus MC

BlinkLab to participate in a clinical study on early diagnosis of dementia in partnership with Erasmus University Medical Center

Bates College

BlinkLab starts a clinical study with Bates College in the US to validate the smartphone-based platform for the assessment of Functional Neurological Disorder

Mental Care Group

BlinkLab partners with Mental Care Group in Europe to improve and accelerate the diagnostic evaluation of ADHD

Columbia University

Partnership aligns with BlinkLab’s strategy to enhance its AI-powered digital platform for sensory phenotyping and promote global adoption.

Latest partnership news

Improving kids autism and ADHD diagnoses through BlinkLab collaboration with Monash University

BlinkLab partners with Monash University for a two-year MAGNET project to enhance autism and ADHD diagnosis using app-based AI technology.

Henk-Jan Boele, MD PhD

•

October 6, 2025

BlinkLab partners with Mental Care Group in Europe to improve and accelerate the diagnostic evaluation of ADHD

BlinkLab is thrilled to partner with Mental Care Group (MCG) to advance ADHD diagnosis through smartphone-based digital sensory phenotyping. By integrating BlinkLab’s innovative app into its diagnostic processes, MCG aims to enhance accuracy, efficiency, and accessibility in ADHD assessments, offering a transformative approach for patients and healthcare providers alike.

Awesome! You're now signed up.

You will receive our newsletter. You can opt out via the newsletter.

Oops! Something went wrong while submitting the form.

Or see mentions of BlinkLab in the media:

BioTechDispatch

BlinkLab (ASX:BB1) has announced the addition of the Thompson Center for Autism and Neurodevelopment at the University of Missouri as the sixth US clinical site for its pivotal FDA 510(k) diagnostic trial.